These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30049919)

  • 21. Targeting protein-bound uremic toxins in chronic kidney disease.
    Niwa T
    Expert Opin Ther Targets; 2013 Nov; 17(11):1287-301. PubMed ID: 23941498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there an association between the plasma levels of uremic toxins from gut microbiota and anemia in patients on hemodialysis?
    Capo-Chichi JCC; Borges NA; de Vargas Reis DCM; Nakao LS; Mafra D
    Int Urol Nephrol; 2022 Jun; 54(6):1271-1277. PubMed ID: 34561817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AST-120 to Target Protein-Bound Uremic Toxins Improves Cardiac Output and Kidney Oxygenation in Experimental Chronic Kidney Disease.
    Sivertsson E; Ceder S; Nangaku M; Hansell P; Nordquist L; Palm F
    Kidney Blood Press Res; 2023; 48(1):114-123. PubMed ID: 36791683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.
    Lekawanvijit S
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.
    Bataille S; Pelletier M; Sallée M; Berland Y; McKay N; Duval A; Gentile S; Mouelhi Y; Brunet P; Burtey S
    BMC Nephrol; 2017 Jul; 18(1):251. PubMed ID: 28747155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein/Fiber Index Modulates Uremic Toxin Concentrations in Hemodialysis Patients.
    Ebersolt M; Santana Machado T; Mallmann C; Mc-Kay N; Dou L; Bouchouareb D; Brunet P; Burtey S; Sallée M
    Toxins (Basel); 2022 Aug; 14(9):. PubMed ID: 36136527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The quest for a better understanding of chronic kidney disease complications: an update on uremic toxins.
    Barreto FC; Stinghen AE; de Oliveira RB; Franco AT; Moreno AN; Barreto DV; Pecoits-Filho R; Drüeke TB; Massy ZA
    J Bras Nefrol; 2014; 36(2):221-35. PubMed ID: 25055363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular incompetence in dialysis patients--protein-bound uremic toxins and endothelial dysfunction.
    Jourde-Chiche N; Dou L; Cerini C; Dignat-George F; Brunet P
    Semin Dial; 2011; 24(3):327-37. PubMed ID: 21682773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight.
    Chao CT; Lin SH
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.
    Iwasaki Y; Kazama JJ; Fukagawa M
    Biomed Res Int; 2017; 2017():3485785. PubMed ID: 28421193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis.
    Hsu HJ; Yen CH; Chen CK; Wu IW; Lee CC; Sun CY; Chang SJ; Chou CC; Hsieh MF; Chen CY; Hsu CY; Tsai CJ; Wu MS
    Gen Hosp Psychiatry; 2013; 35(1):23-7. PubMed ID: 23044245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indoxyl sulfate in uremia: an old idea with updated concepts.
    Berg AH; Kumar S; Karumanchi SA
    J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34981787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
    Wu CL; Tarng DC
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between indoxyl sulfate and skeletal resistance in hemodialysis patients.
    Goto S; Fujii H; Hamada Y; Yoshiya K; Fukagawa M
    Ther Apher Dial; 2010 Aug; 14(4):417-23. PubMed ID: 20649763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comment on Indoxyl Sulfate-Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358.
    Barreto FC; Barreto DV; Stinghen AEM; Massy ZA
    Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28420181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.
    Lim YJ; Sidor NA; Tonial NC; Che A; Urquhart BL
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33668632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indoxyl sulfate, a valuable biomarker in chronic kidney disease and dialysis.
    Tan X; Cao X; Zou J; Shen B; Zhang X; Liu Z; Lv W; Teng J; Ding X
    Hemodial Int; 2017 Apr; 21(2):161-167. PubMed ID: 27616754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indoxyl sulfate exacerbates low bone turnover induced by parathyroidectomy in young adult rats.
    Hirata J; Hirai K; Asai H; Matsumoto C; Inada M; Miyaura C; Yamato H; Watanabe-Akanuma M
    Bone; 2015 Oct; 79():252-8. PubMed ID: 26112820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.